Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot76410.32687/0869-866X-2021-29-6-1433-1438Научная статьяThe alteration of the structure of mortality of endocrine system diseases, nutrition disorders and metabolic disturbances in individuals of able-bodied age and older in conditions of pandemicSabgaydaT. P.tsabgaida@mail.ruEdelevaA. N.-TarasovN. A.-The Federal State Budget Institution “The Central Research Institute for Health Organization and Informatics” of Minzdrav of RussiaThe State Budget Institution “The Research Institute of Health Care Organization and Medical Management of the Moscow Health Care Department”101220212961433143811122021Copyright © 2021,2021The elderly age and endocrine diseases are among death risk factors at contamination with new coronavirus infection. To reply the question of how the influence of these risk factors is summing up, differences were determined concerning patterns of changes in structure of mortality of endocrine system diseases, nutrition disorders and metabolic disturbances in individuals of able-bodied age and older against the background of COVID-19 pandemic.on the basis of information from the Moscow database of deaths of endocrine system diseases, nutrition disorders and metabolic disturbances, the changes in contribution of individual diseases to the death causes structure in 2019-2021 were analyzed. The groups of individuals of able-bodied age and older were compared.It was established that in both groups rate of indicating SARS-CoV-2 virus infection as concomitant disease decreased while rate of indicating concomitant diseases at death of COVID-19 increased. The group differences in changes of structure of death causes were established in 2021. The percentage of undetermined forms of diabetes and obesity in structure of death causes increased in the elderly, while in individuals of able-bodied age increased. The percentage of obesity as concomitant disease of death of COVID-19 in individuals of able-bodied age increased and did no change were detected in the elderly group. The input of poly-glandular dysfunction as consequence of old infection into mortality is five times higher among individuals of able-bodied age.On the basis of received results, assumption was made SARS-CoV-2 virus contamination ruinously affects development of pathological process under endocrine diseases regardless of age, while age affects spreading of endocrine diseases and degree of resistance to development of infectious process directly. The differences in patterns of changes of structure of death causes of population of able-bodied age and older are associated with low quality of diagnostics of death causes in individuals of elder age groups.elderly agedeath causesquality of diagnosisconcomitant diseasesdeath riskhealthструктура причин смертикачество диагностики причин смертисопутствующие заболеванияриск смертивнимание к здоровью пожилых[Sun H., Ning R., Tao Y., Yu C., Deng X., Zhao C. Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study. J. Am. Geriatr. Soc. 2020;68(6):E19-E23. doi: 10.1111/jgs.16533][Wu Z., McGoogan J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648][Трошина Е. А., Мельниченко Г. А., Сенюшкина Е. С., Мокрышева Н. Г. Адаптация гипоталамо-гипофизарно-тиреоидной и гипоталамо-гипофизарно-надпочечниковой систем к новому инфекционному заболеванию-COVID-19 в условиях развития COVID-19-пневмонии и/или цитокинового шторма. Клиническая и экспериментальная тиреоидология. 2020;16(1):21-7. doi: 10.14341/ket12461][Мокрышева Н. Г., Галстян Г. Р., Киржаков М. А., Еремкина А. К., Пигарова Е. А., Мельниченко Г. А. Пандемия COVID-19 и эндокринопатии. Проблемы эндокринологии. 2020;66(1):7-13. doi: 10.14341/probl1237611][Wu Z., McGoogan J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648][Сабгайда Т. П., Иванова А. Е., Руднев С. Г., Семенова В. Г. Причины смерти москвичей до и в период пандемии COVID-19. Социальные аспекты здоровья населения [сетевое издание]. 2020;66(4). Режим доступа: http://vestnik.mednet.ru/content/view/1177/30/lang,ru/ (дата обращения 30 июля 2021). doi: 10.21045/2071-5021-2020-66-4-1][Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054-62. doi: 10.1016/S0140-6736(20)30566-3][Mahase E. Delta variant: What is happening with transmission, hospital admissions, and restrictions? BMJ. 2021;373:n1513. doi: 10.1136/bmj.n1552][O’Dowd A. Covid-19: Cases of delta variant rise by 79%, but rate of growth slows. BMJ. 2021;373:n1596. doi: 10.1136/bmj.n1596][Dworakowska D., Grossman A. B. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471-4. doi: 10.1007/s12020-020-02364-8][Pal R., Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J. Endocrinol. Investigat. 2020;43(7):1027-31. doi: 10.1007/s40618-020-01276-8][Porcheddu R., Serra C., Kelvin D., Kelvin N., Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARSCOV-2 in Italy and China. J. Infect. Dev. Ctries. 2020;14:125-8. doi: 10.3855/jidc.12600][Pinto L. C., Bertoluci M. C. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis. Arch. Endocrinol. Metab. 2020;64:199-200.][Nattrass M., Lauritzen T. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? Int. J. Obes. 2000;24(3):S21-S31.][Баранов В. С., Баранова Е. В. Генетический паспорт - основа активного долголетия и максимальной продолжительности жизни. Успехи геронтологии. 2009;22б(1):84-91.][Сабгайда Т. П., Эделева А. Н., Тарасов Н. А. Качество учета причин смерти лиц старше трудоспособного возраста. Проблемы социальной гигиены, здравоохранения и истории медицины. 2020;28(S2):1108-12. doi: 10.32687/0869-866X-2020-28-s2-1108-1112][Сабгайда Т. П., Тарасов Н. А., Евдокушкина Г. Н. Смертность от сахарного диабета в ракурсе множественных причин смерти: проблемы кодирования. Проблемы социальной гигиены, здравоохранения и истории медицины. 2019;27(6):1043-8. doi: 10.32687/0869-866X-2019-27-6-1043-1048][Сабиров И. С., Мамедова К. М., Султанова М. С., Кожоев М. З., Ибадуллаев Б. М. Ожирение и новая коронавирусная инфекция (COVID-19): взаимовлияние двух пандемий. Scientific Heritage. 2021;63(2):30-8. doi: 10.24412/9215-0365-2021-63-2-30-38][Dhurandhar N. V., Bailey D., Thomas D. Interaction of obesity and infections: interaction of obesity and infections. Obes. Rev. 2015;16:1017-29.][Nonchev B., Argatska A. Autoimmune polyglandular syndrome in a postmenopausal woman after COVID-19 infection. Revista Argentina de Endocrinologia y Metabolismo. 2021;58(SUPPL 1):196.][Об утверждении Концепции демографической политики Российской Федерации на период до 2025 года: Указ Президента Российской Федерации от 09.10.07 № 1351. Режим доступа: http://base.garant.ru/191961/ (дата обращения 25.06.2021).][Башкирева А. С. Инновационные геронтотехнологии в развитии стратегии действий в интересах граждан старшего поколения в РФ. Вестник Росздравнадзора. 2016;(4):19-24.][Кауров Б. А., Матюхина Е. Б. Особенности частотного спектра заболеваний и полиморбидности у пожилых людей и долгожителей. Клиническая геронтология. 2014;20(1-2):66-71.]